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Although  the presence  of endotoxin  has  been  suspected  in  the  circulating 
blood of patients  suffering from Gram-negative infections, it was not possible 
until recently to produce evidence to support this contention. 
The unusual  sensitivity  of the  rabbit  skin  to endotoxin in  the presence  of epi- 
nephrine  (accelerated Shwartzman reaction) led us to use this reaction as a  test for 
circulating endotoxin (1). As described by Thomas (2), a striking hemorrhagic necrosis 
develops at the intracutaneous site of epinephrine injection, if the animal has received 
an intravenous injection of endotoxin during the preceding 4 hours. When pla~na from 
infected patients is utilized for the intravenous injection, positive results are reliably 
obtained in patients with protracted hypotension or shock. When attempts were made 
to estimate the quantity of endotoxin present by injecting known amounts of endo- 
toxin in a vehicle of normal human plasma, and in saline,  it was found that human 
plasma mixed with endotoxin not only enhances  the local reactivity of the rabbit 
to intracutaneous  injections of epinephrine,  but also potentiates  the lethal effect of 
endotoxin  administered  intravenously  by  approximately  10,000-fold. 
Plasma has been reported both to potentiate, and to inhibit the effects of endotoxin. 
Farr (3) found a tenfold enhancement of pyrogenic and leucocytic effects of Salmonella 
typhosa vaccine in the rabbit, when mixed with rabbit plasma. LeQuire (4) confirmed 
this potentiation and showed that it was not abolished by prior treatment with hepaHn. 
Grant  (5)  found that  the potentiation  of pyrogenlc effect by plasma could not be 
demonstrated in ~nlmal~ rendered tolerant to endotoxin. Farret al. (6) confirmed that 
the pyrogenlc effect of endotoxin in rabbits was augmented by both human and rabbit 
plasma, and showed that the serum of tolerant animals failed to produce this augmen- 
tation. They believed this to be due to humoral inhibitors.  All of these investigators 
were concerned with pyrogenic effects,  and the amounts of human plasma and endo- 
toxin utilized by Farr et al. (6) are too small to produce effects of the kind to be re- 
ported. 
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Inhibition of  the pyrogenic effect  of  endotoxin by incubation with homologous 
human plasma was reported by Hegemann (7, 8) and confirmed by Goodale et al. (9). 
Inhibition of pyrogenic effects was also noted on incubation with homologous plasma 
of rabbits (10-13), rat (18),  and the horse  (15).  Hegemann (16)  attributed the in- 
activation to the presence of properdin. Landy et al.  (14)  were able to inhibit the 
effects  of  endotoxin by incubation with heterologous plasma  (human) and testing 
the mixture in the rabbit. These workers were unable to demonstrate plasma inhibi- 
tion in an homologous system (rabbit), but did find inhibitors present in guinea pig 
and mouse plasma, tested in the rabbit. The same authors also observed an inhibition 
of tumor-damaging potency of lipopolysaccharides, as well as other biologic effects 
of  endotoxins, on incubation with human serum. Ho and Kass  (18)  found the in- 
hibitor to be in Cohn fractions III and IV in human plasma tested in rats (17). Rowley 
et al. found that alkaline phosphatase in serum has a  high degree of specificity for 
the  phosphate  ester  bonds of  lipopolysaccharides  (19).  Westphal,  who  suggested 
that the active portion of lipopolysaccharides is lipoid fraction "A," noted that this 
was inactivated by incubation with horse serum (20).  Rosen eta/.  (21)  were of the 
opinion that inactivation may be due to the iron content of serum or plasma. Most 
authors have found that the inhibitory action is destroyed by temperatures above 
60°C for several hours but not at 56°C for 30 minutes (13, 14, 17, 22, 23). 
Materials and Methods 
Test Animals.--Albino  rabbits of either sex, weighing between 1.0 and 1.5 kg were used. 
No animal subjected to previous experimentation was used, and tests were carried out during 
summer, fall, and winter months. 
Plasma Samples.--At  first, fresh serum or heparinized plasma (1 nag heparin/1 ml of blood) 
from blood samples obtained from human volunteers was used. It was then found that plasma 
obtained from citrated  bank blood was equally effective, and this was the source of plasma 
for the experiments reported here. Plasma obtained by centrifugation in a refrigerated centri- 
fuge (15 minutes at 4000 re,  M) was kept frozen until used. Serum was prepared under stand- 
ard conditions; the blood was allowed to clot for 2 hours at 37°C. It was then centrifuged 
and the supernatant removed. 
Endotoxin.--Purified lipopolysaccharide Salmondla enterltides No. 127402 (Dffco Labora- 
tories, Inc., Detroit)  was used. The material was stored in dry form in a refrigerator and 
dissolved in 0.9 per cent saline prior to use. In all instances, pyrogen-free plastic syringes and 
tubes were used. 
Drugs.--Hydrocortisone sodium succinate (solucortef), The Upjohn Company, Kalamazoo, 
Michigan; Heparin sodium ~.s.P., The Vitarine Company, New York; Normal serum albumin 
(human) (albumisol) 25 per cent, Merck Sharp & Dohme, West Point, Pennsylvania; Polio- 
myelitis  immune globulin,  Cutter  Laboratories,  Berkeley; Epinephrine  tr.s.l,.  (1:1000), 
Vitarine. 
Standard Injection Procedure.--Endoto~dn, reconstituted daily in 0.9 per cent saline, was 
diluted to proper dose and mixed immediately prior to injection with plasma or saline as the 
vehicle. 7 ml of plasma was used in all experiments, unless otherwise stated.  Injections were 
made in the marginal vein of the rabbit ear. ~Animals  were observed hourly for 4 hours, and 
again at 24 hours. 
Skin Tests.--Epinephrine was diluted so as to contain either 100 gg or 50/~g in 0.2 ml of 
0.9 per cent saline. Duplicate skin sites were injected intradermally on the shaved abdomen 
of the rabbit. The skin tests were read at 4 hours and at 24 hours. A test was considered 
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Tabulation of Results.--The end-point in these studies was death of the test animal. This 
frequently occurred within 1 hour, and usually within 4 hours. Animals alive at 24 hours 
after injection were considered to have survived. The results are expressed as a fraction, in 
which the numerator is the number of animals which died, and the denominator the number 
of animals tested. Thus a result of ~o would indicate a 20 per cent mortality. 
RESULTS 
1.  Potentiation of Lethal Effect  of Endotoxin by Human Plasma or Serum.- 
Table I  shows that the majority of the rabbits survived the  injection of endo- 
TABLE  I 
Potentiation of Lethal Effect of Endotoxin by Human Plasma 
Dose of endotoxin 
lO00 
500 
200 
100 
50 
20 
lO 
5 
1 
0.5 
0.25 
0.1 
0.05 
0 
No. of rabbits dying/no, of rabbits injected 
0.9 per cent saline 
o/5 
o,s 
0/4 
1/5 
2/8 
2/lO 
o/s 
0/6 
o/8 
0/5 
o/5 
0/5 
0/5 
Hl~man plasma 
5/5 
5/5 
5/5 
5~ 
9D 
9/10 
6/8 
5~ 
4/7 
4D 
3D 
3N 
0/4 
0/12 
toxin in saline, in single doses up to 1000  #g. When human plasma (and in a 
few instances,  serum)  was used as the test vehicle, amounts  of endotoxin as 
small as 0.1 gg produced a high mortality rate. Comparable batches of animals 
given endotoxin in saline, and endotoxin in plasma, were tested at the same 
time. 
The death  of these  animals  was  quite  characteristic.  The  rabbits  became 
lethargic, dyspnoic, and stuporous, and frequently expired within an hour. On 
lifting  the  dead  animal, bloody  urine  was  usually  found. At  autopsy, there 
was the  lack  of significant  findings  associated  with  death  of  animals given 
large  injections  of  endotoxin  in  saline.  Gross  and  microscopic  hemorrhage 
was noted in the urinary tract, including the tubules, but there was no evidence 
of fibrin  deposition,  and  the  remaining  organs  were  normal,  both  on  gross 
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2.  Enhancement  of Skin  Reactivity  to  Epinephrine  in  the  Presence  of Endo- 
toxin,  by  Human  Plasma  or Serum.--Results  of  skin  tests  for  reactivity  to 
epinephrine  in  the  presence of circulating  endotoxin  are  shown  in Table II. 
Although it was originally planned to carry out skin tests on all animals sub- 
jected to tests for lethal effect, it was found  that  the early death of animals 
given endotoxin  and  human plasma precluded  determination  of the  skin  re- 
TABLE II 
Skin Reactivity to Efinephrine in the Presence of Endotoxin 
Dose of endotoxin 
/zg 
20 
10 
5 
1 
0.5 
0.25 
0.1 
0.05 
No. posltlve/No, injected 
0.9 per cent saline 
3/4 
2/2 
4/5 
3/5 
4/5 
3/5 
3/s 
1/5 
Human plasma* 
1/1 
2/2 
6/6 
4/6 
1/1 
3/4 
* In surviving animals 
TABLE  HI 
Comparative Effects of Heterologous and Homologous Plasma  in Potentiation of Lethal Effect 
of Endotoxin 
Vehicle 
0.9 per cent saline ....................................... 
Human plasma .......................................... 
Guinea pig plasma ....................................... 
Rat plasma ............................................. 
Rabbit plasma (homologous)  .............................. 
Endotoxln dose 
10 Dg  20/tg 
2/lo  o/8 
9/10  6/8 
4/4  3/3 
2/3 
1/5  0/4 
action in many instances. For this reason the data in Table II are not a repre- 
sentative sampling of experiments carried out simultaneously at different dose 
levels for endotoxin in plasma or saline,  but  instead  the results represent  the 
accumulated  observations  on  survivors.  Although  these  results  convey  the 
impression that potentiation of skin reactivity to epinephrine in the presence of 
endotoxin is produced by plasma, experiments were not carried out extensively 
in the dose range below 0.1 t~g to substantiate this point. 
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all of 15 animals  given endotoxin  (1 to 200 #g) human plasma mixtures  which 
had first been incubated at 56°C for 30 minutes, in order  to abolish  the lethal 
effect of the mixture. 
3.  The Effect of Heterologous and Homologous Plasma in Potentiation.-- 
In a separate series of experiments, rabbit plasma was compared with heterologous plasma 
in its capacity to potentiate the lethal effect of endotoxin. Blood was obtained from rabbits, 
guinea pigs, and rats, of no particular  strain, by cardiac puncture,  and plasma removed after 
centrifugation of heparinized samples. Endotoxin dosages of 10 and 20 pg were utilized, since 
at this level 75 to 90 per cent of animals given human plasma die, while 80 to 100 per cent 
survive if saline is used. 
As Table III shows, homologous plasma does not cause a  significant  rise in 
mortality,  whereas  mixtures  containing  human,  guinea  pig,  and  rat  plasma 
strikingly increase  the lethal outcome. In individual experiments,  the impres- 
sion was gained that the lethal effect of mixtures with guinea pig and rat plasma 
was not as great, since such animals died between 12 and 24 hours, in contrast 
to the early mortality when human plasma was used. 
4.  Effect of Heat on Potentiating Activity.-- 
Three groups d  rabbits were used. Group 1 received 100 or 200 pg of endotoxin in human 
plasma, the mixture having been heated  at 56°C for 30 minutes prior to injection.  Group 2 
received human plasma heated in the same way, with a similar dose of fresh endotoxin added 
just prior to injection. Group 3 received 100 or 200 ~tg of endotoxin, heated  at 56°C for 30 
minutes, and added to fresh human plasma just prior to injection. 
TABLE IV 
Heat Inactivation of Plasma Potentiation of Lethal E~re~t of Endotoxin 
VeMc~ 
Endotoxin in saline 
Endotoxin in plasma 
Endotoxin in plasma, heated  (56°C for 30 min.) 
Endotoxin plus heated plasma 
Heated endotoxin plus plasma 
Endotoxin dose 
200/zg  lO0/zg 
0/4  1/5 
sis  sis 
o/s  o/s 
1/5 
5/5 
Incubation  of  the  endotoxin-plasma  mixture  at  this  temperature  com- 
pletely nullified the potentiation of lethal effect. Table  IV  shows  clearly  that 
this  is not due  to inactivation  of the  endotoxin by heat,  but  to  inactivation 
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5.  Plasma Fraction Responsible for Potentiation.-- 
Groups of rabbits were given 10 ~g of endotoxin to which was added, respectively,  1.3 ml 
of human serum albumin, 0.42 ml of human gamma globulin, and 1.3 ml of albumin plus 0.42 
ml of gamma globulin. These represent the approximate quantities  of these protein  fractions 
in 7 ml of human plasma. A fourth group was given 2.6 ml of human serum  albumin,  the 
approximate total protein content of 7 ml of normal human plasma. 
TABLE V 
Plasma Protein Fractions in Relation to Potentiation of Lethal Effect of Endotoxin 
Vehicle  Endotoxin, 10/~g 
In saline 
In plasma 
In 1.3 ml human serum albumin 
In 0.42 ml human gamma globulin 
Albumin plus globulin 
In 2.6 mi human serum albumin 
0/8 
6/8 
0/5 
0/5 
0/5 
o/5 
TABLE VI 
Rdation  between Dose of Endotoxin and Quantity of Plasma Needed for Potentiation 
Plasma 
ml 
7 
6 
5 
4 
3 
2 
1 
200/~g 
5/5 
s/5 
5/5 
1/5 
i00/zg 
5/s 
s/s 
s/s 
2/s 
2/5 
Endotoxln 
20#g 
9/10 
6/7 
2/5 
1/5 
O/5 
10Dg 
6/8 
o/2 
o/2 
None of these  (Table  V)  separately,  in combination,  and in amounts com- 
parable  to  total  protein  content,  potentiate  the  lethal  effect  of  endotoxin. 
Moreover,  since serum is  as effective as plasma,  fibrinogen is  apparently  not 
involved. It is probable that the potentiating factor, if it is a  protein, will be 
found in the alpha or beta globulin fraction. 
6.  Relationship  between Endotoxin  Dose and Amount of Plasma Required for 
Potentiation.--When  the  dosages  of endotoxin  and  plasma  are varied  (Table 
VI) it is evident that potentiation of lethal effect is a  function of the dosage of 
both endotoxin and plasma.  When 10 to 20 ~g of endotoxin are used, a  lethal 
effect is not consistently seen unless 6 ml or more of plasma are used. Although 
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range of 1 to 1.5 kg used) were somewhat more susceptible to lethal effect of 
endotoxin. Approximately 5 ml/kg of human plasma are required to consistently 
potentiate the lethal effects of small doses of endotoxin in the rabbit. 
7.  Effect of Induced Tolerance in the Test Animal on Potentiatlon.--Four rab- 
bits were rendered tolerant by administration of increasing doses of endotoxin, 
until they were refractory to 200 #g over a  2 week period.  On the  15th day, 
each animal was given an intravenous injection of 20 #g of endotoxin in 7  ml 
of human plasma, and intracutaneous injections of epinephrine were made. As 
previously shown, the mortality at this level is 90 per cent (Table I), and skin 
tests are uniformly positive. All of the tolerant animals survived, and all skin 
tests were negative. Thus, tolerance to endotoxin abolishes the lethal potenti- 
ality of an endotoxin-human plasma mixture. 
8.  Effect of Timing and Sequence of Dosage.--To  investigate the possibility 
TABLE VII 
Effea of Timing and Sequence on Plasma Potentiation of Endotoxin 
time interval. 
ml human plasma FOLLOWED by 20 gg endotoxin 
ml human plasma PRECEDED by 20 gg endotoxin 
5 mln.  30 min.  I  3 hrs.  7 hrs. 
I 
3/4  6/9  3/4  1/5 
4/4  8/9  4/6  2/5 
that  endotoxin must first combine, or form a  complex with,  the potentiating 
factor in human plasma, in order to produce an increased lethal effect, both the 
timing and sequence of plasma and  endotoxin injections  were varied  (Table 
VII). 
In one group of rabbits,  the intravenous injection of 20 ~g of endotoxin in saline was 
followed by the injection of 7 ml of plasma at intervals of either 5 minutes, 30 minutes, 3 
hours, or 7 hours. A second group of animals received 7 ml of plasma as the initial injection, 
followed by the same dose of endotoxin in saline at either 5 minutes, 30 minutes, 3 hours, or 
7 hours. 
The results indicate that the order in which the injection of endotoxin and 
plasma  is  made  does  not  influence  the  development  of an  enhanced  lethal 
effect, and suggest that potentiation may occur even when the injections are 
separated by hours. 
9.  Effect of Heparin and Pretreatmenl  witk Cortisone  on the Lethal Effect.-- 
Pretreatment  with  heparin,  which  prevents  the  generalized  Shwartzman  re- 
action, and cortisone, which does not, was investigated in relation to the en- 
hanced lethal effect. 
Fifteen rabbits were given 50 mg of heparin, and S rabbits were given 100 rag of heparin, 
1 minute prior to the intravenous injection of 20/~g of endotoxin in 7 ml of human plasma. 
Control experiments showed that this dosage of heparin effectively blocks blood coagulation 252  LETHAL  EFFECT  OF ENDOTOXIN 
in the rabbit. Five rabbits were given 25 mg of hydrocorfisone intramuscularly twice a  day 
for 3 days. On the 4th day, a similar dose was given and 20 gg of endotoxin and 7 ml of plasma 
injected intravenously. 
The results  of these experiments are shown in Table VIII.  The mortality 
figures are essentially the same as these seen with endotoxin and plasma alone, 
at these dosages. 
10.  Inhibition of the Lethal Effect by Incubation  of Endotoxin  and Plasma.- 
Inasmuch as data in the literature indicated the presence of inhibitory factor in 
plasma, experiments were done to detect inhibition of the lethal effect. 
TABLE  VIII 
Effect of Pretreatment with Heparin or Cortisone on Potentiation  of Lethal Effect  of Endotoxin 
by Plasma 
Pretreatmcnt with  20/zg endotoxin, plus 
7 ml human plasma 
Heparin, S0 mg ................................................  10/1S 
Heparin, 100 mg ...............................................  5/5 
Cortisone, 25 mg b.i.d, for 3  days ................................  5/5 
TABLE  IX 
Inhibition of Lethal Effect of Endotoxin  by Incubation  with Heterologous Plasma 
Incubation  time 
Endotoxin 
/zg 
5O0 
2O0 
100 
20 
0 
5/5 
5/5 
5/5 
9/10 
2 hrs. 
5/5 
3/6 
3/6 
4 hrs. 
3/5 
2/3 
O/5 
24 hrs. 
1/4 
Endotoxin, in amounts ranging from 20 to 1000/~g, was incubated at 37°C 
with  7 ml of plasma,  for periods of 2, 4, and 24 hours. These mixtures were 
injected into test animals,  and compared with suitable endotoxin saline con- 
trois. Incubation of endotoxin alone, or of human plasma alone, did not affect 
their potency when mixed together just prior to injection. In some experiments, 
fresh endotoxin was added to the incubated mixture, with restoration of the 
lethal effect. 
In order to demonstrate plasma inhibition of the lethal effect of endotoxin, 
it would be desirable to show that the lethal effect of the incubated mixture is 
less than that of a comparable mixture of endotoxin in saline. At the dosages 
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comparison  could  not be made. However,  a  comparison  with the mortality 
rates in the other experiments in this study suggests that inhibition does occur 
(Table IX). This is supported by the observation that addition of fresh endo- 
toxin to the incubated mixture restores  the lethal effect;  and  this  suggests 
further than the plasma factor responsible for potentiation is distinct from that 
concerned with inhibition. 
DISCUSSION 
The above  experiments  demonstrate the presence,  in human plasma, of a 
substance which  produces  a  remarkable potentiation of the lethal effect  of 
endotoxin administered intravenously  to a rabbit. In the low dose range studied, 
there is an inverse plasma-endotoxin dose relationship,  such that smaller doses 
of endotoxin require larger quantities of plasma to produce an equivalent effect. 
A similar enhancement of the lethal action of endotoxin was found with the 
use of plasma from guinea pigs and rats, though not with rabbit plasma. It is 
not clear whether this represents  a specific deficiency of the potentiating factor 
in the rabbit, or indicates an immune mechanism based on species differences. 
It is of considerable interest that prior incubation of endotoxin with plasma 
is unnecessary,  and that during a period of 3 hours, neither the sequence  nor 
the timing of endotoxin and plasma injections appears to interfere with evoca- 
tion of an increased  lethal effect. In previous  work on the augmentation of 
pyrogenic effect of endotoxin (24, 25)  it was  speculated that an endotoxin- 
plasma factor complex forms in vitro,  and exhibits  greatly increased  activity 
in vivo. 
In view of the clearance curves of CPl-labeled  endotoxin in the rabbit (26) 
which indicate more than 90 per cent disappearance  from the circulation in 8 
minutes, it is improbable that endotoxin, in the amounts used (20/~g), persist 
in the circulation long enough to permit the in vivo formation of a "complex" 
3 hours later. Similarly, altered function of the reticuloendothelial system as an 
explanation of the increased  lethal effect seems unlikely, in view of the small 
quantities of endotoxin used. This is supported by preliminary studies which 
fail to demonstrate depression  of RES phagocytic function by injections of 
plasma in the amounts used in this study. 
An alternative mechanism would be that endotoxin and heterologous plasma 
both act directly, and interchangeably, upon the reactive system of the rabbit 
in such a manner as to produce death, when both components are present. 
That endotoxin is a vital component in this enhanced lethal reaction is indi- 
cated not only by the minute doses which are effective, but also by the fact 
that tolerance to endotoxin in the test animal abolishes  the potentiation of 
lethal effect produced by human plasma. 
Pretreatment with heparin does not protect the recipient animal against the 
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accord with the failure to find, at autopsy, fibrin deposition in pulmonary and 
other capillary beds pointing against rapid polymerization of fibrinogen as a 
cause of death. Moreover, in contrast to the protection ordinarily conferred by 
pretreatment with cortisone against lethal effect (though not against the gener- 
alized Shwartzman reaction)  (27), in our experiments cortisone failed to protect 
against the potentiation of lethal effect by plasma. 
Since the demonstration of a plasma inhibitor distinct from the potentiating 
factor would require a reduction in lethal effect below that found with injection 
of endotoxin in saline, these studies do not permit a positive statement on this 
point. However,  the lethality of incubated mixtures of endotoxin and plasma, 
as compared to that produced by fresh endotoxin and plasma injected immedi- 
ately, strongly suggests  that inhibition (or  decay of endotoxin activity) oc- 
curred during incubation. The restoration of lethal effect  upon  addition of 
fresh endotoxin, still in doses too small to be effective if given in saline, indicates 
that the loss of activity produced by incubation of endotoxin and plasma at 
37°C is not achieved at the expense of the potentiating factor. 
SUM~.ARY 
The intravenous injection of endotoxin in human plasma into rabbits pro- 
duces a marked potentiation of lethal effect, when compared  to the mortality 
associated with comparable  doses of endotoxin in saline alone.  A similar  en- 
hancement was noted with other heterologous plasma (guinea pig, rat) but not 
with homologous plasma.  The potentiating factor is  not in the albumin or 
gamma globulin fractions, is not concerned with fibrinogen, and is heat-labile. 
Tolerance  of  the  recipient  animal  to  endotoxin destroys  the  lethal  effect. 
Within a period of 3 hours, endotoxin and human plasma may be administered 
separately, without regard to timing or sequence,  without loss of the lethal 
effect. The enhancement of lethal effect is not avoided by pretreatment with 
heparin or cortisone.  Preliminary experiments  indicate that the loss of lethal 
effect found after incubation of endotoxin-plasma  mixtures may be due to a 
separate inhibitor, but is not due to loss of the potentiating factor. 
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